NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 388 filers reported holding NEKTAR THERAPEUTICS in Q3 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $282,000 | -15.6% | 15,819 | +2.2% | 0.01% | -8.3% |
| Q4 2019 | $334,000 | -29.7% | 15,485 | +9.5% | 0.01% | -36.8% |
| Q1 2019 | $475,000 | +4.4% | 14,146 | +2.1% | 0.02% | -13.6% |
| Q4 2018 | $455,000 | -42.7% | 13,857 | +6.3% | 0.02% | -33.3% |
| Q3 2018 | $794,000 | +792.1% | 13,033 | +612.6% | 0.03% | +725.0% |
| Q2 2018 | $89,000 | -95.4% | 1,829 | -94.3% | 0.00% | -89.7% |
| Q4 2017 | $1,933,000 | +136.6% | 32,367 | -5.0% | 0.04% | +129.4% |
| Q3 2017 | $817,000 | +24.5% | 34,053 | +1.5% | 0.02% | +13.3% |
| Q2 2017 | $656,000 | +203.7% | 33,545 | +264.6% | 0.02% | +275.0% |
| Q1 2017 | $216,000 | – | 9,201 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 598,400 | $10,083,000 | 3.98% |
| Opus Point Partners Management, LLC | 348,583 | $5,874,000 | 3.88% |
| Camber Capital Management LP | 3,500,000 | $58,975,000 | 3.81% |
| 1492 Capital Management LLC | 180,601 | $3,043,000 | 2.21% |
| Virtus ETF Advisers LLC | 38,260 | $645,000 | 1.77% |
| Cormorant Asset Management, LP | 765,156 | $12,893,000 | 1.54% |
| Rhenman & Partners Asset Management AB | 581,000 | $9,790,000 | 1.48% |
| Granahan Investment Management | 2,082,155 | $35,084,000 | 1.21% |
| BRIDGER MANAGEMENT, LLC | 1,563,862 | $26,351,000 | 0.87% |
| RICE HALL JAMES & ASSOCIATES, LLC | 899,531 | $15,157,000 | 0.87% |